- Home
- LTRX vs NVCT Comparison
LTRX vs NVCT Comparison
Compare LTRX & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTRX | NVCT |
|---|---|---|
| Founded | 1989 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.4M | 220.0M |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LTRX | NVCT |
|---|---|---|
| Price | $6.14 | $8.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $6.50 | ★ $15.33 |
| AVG Volume (30 Days) | ★ 572.4K | 46.2K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $122,923,000.00 | N/A |
| Revenue This Year | $1.12 | N/A |
| Revenue Next Year | $15.27 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.91 | $5.55 |
| 52 Week High | $8.24 | $11.52 |
Technical Indicators
Market Signals| Indicator | LTRX | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 52.10 | 52.48 |
| Support Level | $6.05 | $8.01 |
| Resistance Level | $6.75 | $9.20 |
| Average True Range (ATR) | 0.34 | 0.42 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 50.93 | 46.43 |
Price Performance
Historical ComparisonAbout LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.